Introducción: A pesar de la mayor demanda de urgencias psiquiátricas infanto-juveniles, las características de este colectivo no han sido definidas con precisión. Objetivos: Analizar variables clínicas y sociodemográficas de los menores de 17 años evaluados en Urgencias Psiquiátricas de un hospital general. Estudiar la adherencia terapéutica y la estabilidad diagnóstica tras la atención urgente. Método: Estudio retrospectivo en una muestra de 218 atenciones psiquiátricas infanto-juveniles durante 7 años (2010-2017). Resultados: Edad media 13,60 años (DE: 2,36). Sexo: 54% mujeres, 46% varones. El número de atenciones psiquiátricas infanto-juveniles aumentó desde 11,6% en 2010 hasta 23,3% en 2016. Motivo de consulta más frecuente: alteraciones conductuales en varones y autolesiones en mujeres. Antecedentes de intento autolítico mujeres: 46,4%, varones: 14%. La mayoría de los pacientes presentaban antecedentes psiquiátricos personales y familiares. Antecedentes somáticos (17,1%), la enfermedad más prevalente fue la epilepsia (9,7%). El 11,5% consumían tóxicos (droga más frecuente: THC), el abuso de alcohol era más prevalente entre las mujeres. Tasa de hospitalización (14,7%), los pacientes más jóvenes precisaban ingreso con mayor frecuencia. En Urgencias se prescribieron psicofármacos en el 62,3% de los casos (grupo más recetado: antipsicóticos 38,9%). Derivación para seguimiento ambulatorio (72,5%), asistencia a la primera consulta (81%), retirada de prescripciones farmacológicas (58%). Estabilidad diagnostica: 77,8%. Conclusiones: Existen importantes diferencias de género en las urgencias psiquiátricas infanto-juveniles. Se trata de un colectivo vulnerable, la mayoría de los pacientes tienen antecedentes psiquiátricos personales y familiares, con perfil socio-demográfico desfavorable. Es necesario mejorar la adherencia terapéutica tras la atención urgente.
IntroductionCausality between THC and psychotic symptoms has been outlined in several studies and a potential role for THC in the development of Schizophrenia remains to be assessed.MethodsRetrospective study undertaken in a sample of 124 patients assessed in an Emergency Department (ED) due to psychotic symptoms. Medical records were reviewed to obtain clinical and sociodemographic variables.Objectives(1) To analyse the prevalence of THC consumption among psychotic patients in ED; (2) to establish the prevalence of cannabis-induced psychotic disorder; (3) to underpin the socio-demographic and clinical variables associated with cannabis-induced psychosis.ResultsPersonal history of cannabis use 31.5% (6.5% as a single drug.) Accumulated time interval of cannabis use prior to the first psychotic episode: 0 – 5 years 15% (3.9% developed psychosis during the first year of cannabis use), 5 – 10 years 9.2%, more than 10 years 20.8%. Cannabis-induced psychotic disorder (F12.5) was diagnosed in 3.3% of the sample. The prevalence of this diagnosis was the same among male and female patients. The highest prevalence of cannabis-induced psychosis was found among 36–50 years old patients (50%). All patients with a diagnosis of Cannabis-induced psychotic disorder had a personal history of THC use and urine tests had been positive for THC in 75% of the cases. Habitat: 75% urban, 25% rural. Marital status: 50% single, 50% married.ConclusionsCannabis use is highly prevalent among patients who present with psychotic symptoms in ED and THC is correlated with psychotic episodes. The prevalence of cannabis-induced psychosis has also increased. Further studies comprising larger samples are warranted.Disclosure of interestThe authors have not supplied their declaration of competing interest.
IntroductionSubstance abuse has been correlated with psychotic disorders albeit more accurate details on causality remain to be assessed. Furthermore, the prevalence and prognosis of substance-induced psychotic disorders have not been clearly established.MethodRetrospective study performed in 124 patients assessed in an Emergency Department (ED) due to psychotic symptoms over a 6-month period. Medical records were reviewed to obtain clinical and socio-demographic variables.Objectives(1) To analyse substance abuse patterns among ED psychotic patients; (2) to estimate the prevalence of substance-induced psychotic disorders in ED; (3) to underpin the socio-demographic and clinical variables associated.ResultsPersonal history of substance abuse: THC 31.5%, alcohol 29%, cocaine 18.5%, benzodiazepines 18.5%, opiates 6.5%, MDMA 4%, amphetamines 3.2%, hallucinogens 2.4%. Accumulated time interval of substance abuse prior to psychotic onset: 0–5 years 15% (3.9% developed psychosis during the first year of cannabis use), 5–10 years 9.2%, more than 10 years 20.8%. Urine testing for drug misuse undertaken in 80.6% of cases: positives 53%, negatives 47%. Among positive urine test results: THC 16.5%, benzodiazepines 16.5%, cocaine 6.1%, opiates 5.1%, alcohol 0.9%, amphetamines 0.8%, hallucinogens 0.8%. Substance-induced psychotic disorder (F19.15) was diagnosed among 20.4% of patients. This diagnosis was 1.5 times more prevalent among males. Forty-eight percent of patients were single, 36% married, 12% divorced, 4% widowers. Habitat: 68% urban, 34% rural. Highest prevalence group 36 – 50 year olds.ConclusionsBoth substance abuse and substance-induced psychotic disorders are highly prevalent in our sample. Their socio-demographic and clinical profile is similar to that found in schizophrenia. Further refinements of these findings are warranted.Disclosure of interestThe authors have not supplied their declaration of competing interest.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.